Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Rashid Khalil

Anesthesiology Toledo, OH Medical Doctor

NPI 1003000142 CMS profile 90590

4126 N Holland Sylvania Rd, Suite 220, Toledo, OH 43623

Open in the dashboard

General payments

$12,793

266 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Rashid Khalil of Toledo, OH is reported in the CMS Open Payments database as having received $12,793 across 266 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Anesthesiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $439 25
2024 General $1,769 46
2023 General $3,069 60
2022 General $3,544 74
2021 General $2,417 44
2020 General $251 6
2019 General $1,303 11

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Rashid Khalil
  • Anesthesiology median
  • Middle half of Anesthesiology
  • National median

In program year 2025, general payments to Rashid Khalil were reported at $439. Among 18,548 Anesthesiology profiles paid that year, the median was $58 and the middle half received between $26 and $153.

Show as a table
Year Rashid Khalil Anesthesiology median Middle half National median
2019 $1,303 $72 $23–$151 $163
2020 $251 $36 $17–$120 $114
2021 $2,417 $49 $21–$135 $132
2022 $3,544 $52 $22–$144 $149
2023 $3,069 $53 $23–$143 $160
2024 $1,769 $55 $25–$150 $164
2025 $439 $58 $26–$153 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Relievant Medsystems, Inc. $3,252 26 payments
  2. Boston Scientific Corporation $2,022 76 payments
  3. Abbott Laboratories $1,726 68 payments
  4. Medtronic, Inc. $1,517 30 payments
  5. Medtronic USA, Inc. $1,057 6 payments
  6. SPR Therapeutics, Inc $1,021 4 payments
  7. Vertos Medical, Inc. $999 17 payments
  8. Nevro Corp. $502 13 payments
  9. Stryker Corporation $284 7 payments
  10. Myoscience Inc. $125 1 payment
  11. Other $288 18 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $8,692 255 payments
  2. Travel and Lodging $3,501 9 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $600 2 payments
Products named General payments · program years 2019–2025
  1. Intracept Pain $2,289 13 payments
  2. Intracept Pain $1,335 10 payments
  3. Intracept Pain $1,335 10 payments
  4. Intracept Pain $1,300 8 payments
  5. PROCLAIM $1,133 45 payments
  6. ADAPTIVESTIM $1,057 6 payments
  7. INTELLIS ADAPTIVESTIM $1,040 21 payments
  8. SPRINT PNS System $1,021 4 payments
  9. mild Device Kit $999 17 payments
  10. Intracept Pain $588 4 payments
  11. Other $4,605 128 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 24 drugs

Part D claims

1,838

Median for Anesthesiology: 322

Drug cost

$52,787

Median for Anesthesiology: $8,738

Branded share of claims

40%

Median for Anesthesiology: 25.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Movantik Naloxegol Oxalate Brand 45 $18,911
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 340 $6,027
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 267 $5,344
Gabapentin Generic 293 $4,512
Belbuca Buprenorphine Hcl Brand 12 $4,389
Pregabalin Generic 111 $3,540
Lidocaine Generic 30 $2,935
Diclofenac Sodium Generic 47 $1,236
Tizanidine Hcl Generic 142 $1,083
Oxycodone Hcl Generic 61 $697

The 10 drugs with the highest cost, of 24 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 3,517 Part D prescribers listed as Anesthesiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 41 billing codes

Paid by Medicare

$101,578

Of which drugs: $24

Medicare patients

316

Average age 70

Services billed

1,369

192 women, 124 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 45%
Depression 44%
Ischemic heart disease 36%
Chronic kidney disease 34%
COPD 32%
Heart failure 27%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, dexamethasone sodium phosphate, 1 mg J1100 Office 20 260 $24

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

266 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Anesthesiology in Ohio

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record